In vivo Microscopic Imaging of Multiple Sclerosis with High Field MRI

  • A. Kangarlu
  • K. W. Rammohan
  • E. C. Bourekas
  • D. W. Chakeres
Part of the Topics in Neuroscience book series (TOPNEURO)


Acquiring the ability to visualize areas of demyelination in the brains of patients with multiple sclerosis (MS) by magnetic resonance imaging (MRI) marked a turning point in the diagnosis of this disease. MRI has enabled the systematic examination of distribution and time-dependent characteristics that lead to the development of long-term clinical disability in MS patients. An understanding of this series of events permits a qualitative and quantitative evaluation by MRI of the effects of therapeutic strategies [1]. Many of the early MRI studies examined the sensitivity of the MRI technique in detecting lesions of MS [2] only. The longterm natural history of MS has also been studied by MRI. It has long been evident that relapses of MS as evident on MRI occur regularly, but that only a small fraction of such exacerbations manifest clinically. Therefore, MRI is essential to directly monitor the progression of disease. Drugs under investigation for their efficacy have been examined for their ability to modify the MRI profile [3], and a favorable effect visible on MRI has become an expected effect of such drugs. However, a disparity has been identified in numerous studies and over the last decade: it has become increasingly evident that lesions seen on conventional MRI may correlate poorly with clinical disability. Therefore, there remain significant imaging challenges to better characterize MS patients by MRI. Defining the white matter lesions is not the complete story.


Multiple Sclerosis Multiple Sclerosis Patient White Matter Lesion Experimental Allergic Encephalomyelitis Gradient Echo 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    McFarland HF, Stone LA, Calabresi PA et al (1996) MRI studies of multiple sclerosis: implications for the natural history of the disease and for monitoring effectiveness of experimental therapies. Mult Scler 2: 198–205PubMedGoogle Scholar
  2. 2.
    Frank JA, Bash C, Stone L et al (1996) Evaluation of magnetic resonance imaging sensitivity in patients with relapsing remitting multiple sclerosis: baseline versus Betaseron treatment trials. Acad Radiol 3S: S173–175PubMedCrossRefGoogle Scholar
  3. 3.
    Richert ND, Zierak MC, Bash CN et al (2000) MRI and clinical activity in MS patients after terminating treatment with interferon beta-lb. Mult Scler 6: 86–90PubMedGoogle Scholar
  4. 4.
    Filippi M, Tortorella C, Rovaris M et al (2000) Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis. J Neurol Neurosurg Psychiatry. 68: 157–161PubMedCrossRefGoogle Scholar
  5. 5.
    Tan IL, van Schijndel RA, Pouwels PJ et al (2000) AJNR Am J Neuroradiol 21: 1039–1042PubMedGoogle Scholar
  6. 6.
    Robitaille P-ML, Abduljalil AM, Kangarlu A et al (1998) Human magnetic resonance Imaging at 8T. NMR Biomed 11: 263–265PubMedCrossRefGoogle Scholar
  7. 7.
    Kangarlu A, Robitaille PML (2000) MR venography in multiple sclerosis. Biological effects and health implications in magnetic resonance imaging. Concepts Magn Reson 12: 321–359CrossRefGoogle Scholar
  8. 8.
    Kangarlu A, Burgess RE, Zhu H et al (1999) Cognitive, cardiac and physiological safety studies in ultra high field magnetic resonance imaging. J Magn Reson Imag 17: 1407–1416CrossRefGoogle Scholar
  9. 9.
    Kangarlu A, Baertlein BA, Lee R et al (1999) Dielectric resonance phenomena in ultra high field magnetic resonance imaging. J Comp Assist Tomogr 23: 820–831Google Scholar
  10. 10.
    Gareau PJ, Wymore AC, Cofer GP, Johnson GA (2002) Imaging inflammation: direct visualization of perivascular cuffing in EAE by magnetic resonance microscopy. J Magn Reson Imaging 16: 28–36PubMedCrossRefGoogle Scholar
  11. 11.
    Pan JW, Coyle PK, Bashir K et al (2002) Metabolic differences between multiple sclerosis subtypes measured by quantitative MR spectroscopy. Mult Scler 8: 200–206PubMedCrossRefGoogle Scholar
  12. 12.
    Reichenbach JR, Barth M, Haacke EM et al (2000) High-resolution MR venography at 3.0 Tesla. J Comput Assist Tomogr 24: 949–957PubMedCrossRefGoogle Scholar
  13. 13.
    Lucchinetti C, Brück W, Parisi J et al (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47: 707–17PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia, Milano 2003

Authors and Affiliations

  • A. Kangarlu
  • K. W. Rammohan
  • E. C. Bourekas
  • D. W. Chakeres

There are no affiliations available

Personalised recommendations